RELATIONSHIPS BETWEEN KAPPA OPIOID RECEPTOR AVAILABILITY, HOARDING BEHAVIORS, AND SUICIDE IDEATION IN PSYCHIATRIC SUBJECTS: RESULTS FROM AN IN VIVO PILOT STUDY USING [11C]EKAP PET

被引：0
|
作者：
Weiss, Emily [1 ]
Hart-Derrick, Victoria [1 ]
Pittenger, Christopher [1 ]
Weed, Mia [1 ]
Nabulsi, Nabeel [1 ]
Matuskey, David [1 ]
Davis, Margaret [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2024年 / 49卷
关键词：
Hoarding Disorder; kappa opioid receptor; Suicide risk factors;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P655
引用
收藏
页码：445 / 445
页数：1
相关论文
共 12 条
  • [1] Role of Kappa Opioid Receptor Availability in Borderline Personality Disorder and Suicidal Behavior: Preliminary Results From an in Vivo [11C]EKAP PET Study
    Davis, Margaret
    Wilson, Olivia
    DeBonee, Sarah
    Nabulsi, Nabeel
    Matuskey, David
    Esterlis, Irina
    BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S169 - S170
  • [2] Kappa Opioid Receptor Availability and Risk for Disordered Eating and Self-Injury: Preliminary Results From an [11C]EKAP PET Study in Borderline Personality Disorder
    Weiss, Emily
    Hillmer, Ansel
    Wagner, Ashley
    Nabulsi, Nabeel
    Matuskey, David
    Esterlis, Irina
    Davis, Margaret
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 335 - 336
  • [3] Kappa Opioid Receptor Availability in Borderline Personality Disorder and Relationship to Suicidal Behavior: Preliminary Results From a [11 C]EKAP PET Study
    Davis, Margaret
    Wilson, Olivia
    Wagner, Ashley
    Nabulsi, Nabeel
    Matuskey, David
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 335 - 335
  • [4] Kappa Opioid Receptor Availability in Borderline Personality Disorder and Relationship to Suicidal Behavior: Preliminary Results From a [11 C]EKAP PET Study
    Davis, Margaret
    Wilson, Olivia
    Wagner, Ashley
    Nabulsi, Nabeel
    Matuskey, David
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 335 - 335
  • [5] Lower Kappa Opioid Receptor Availability in Alcoholics: A PET Imaging Study with [11C]LY2795050
    Vijay, Aishwarya
    Cavallo, Dana
    Goldberg, Alissa
    Nabulsi, Nabeel
    Najafzadeh, Soheila
    Lin, Shu-Fei
    Lara-Jaime, Teresa
    Huang, Yiyun
    Krishnan-Sarin, S.
    Morris, Evan
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [6] Mu-opioid receptor availability in schizophrenia patients: a PET study using [11C]-carfentanil
    Ashok, A. H.
    Marques, T.
    Rabiner, E.
    Howes, O.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S907 - S907
  • [7] Measurement of central µ-opioid receptor binding in vivo with PET and [11C]carfentanil: a test–retest study in healthy subjects
    Jussi Hirvonen
    Sargo Aalto
    Nora Hagelberg
    Anu Maksimow
    Kimmo Ingman
    Vesa Oikonen
    Jussi Virkkala
    Kjell Någren
    Harry Scheinin
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36
  • [8] Measurement of central μ-opioid receptor binding in vivo with PET and [11C] carfentanil: a test-retest study in healthy subjects
    Hirvonen, Jussi
    Aalto, Sargo
    Hagelberg, Nora
    Maksimow, Anu
    Ingman, Kimmo
    Oikonen, Vesa
    Virkkala, Jussi
    Nagren, Kjell
    Scheinin, Harry
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (02) : 275 - 286
  • [9] Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: A PET study using [11C]carfentanil
    Tuominen, Lauri
    Salo, Johanna
    Hirvonen, Jussi
    Nagren, Kjell
    Laine, Pauliina
    Melartin, Tarja
    Isometsa, Erkki
    Viikari, Jorma
    Raitakari, Olli
    Keltikangas-Jarvinen, Liisa
    Hietala, Jarmo
    NEUROIMAGE, 2012, 61 (03) : 670 - 676
  • [10] Comparing m-opioid receptor availability and opioid/β-endorphin release between individuals with gambling disorder, alcohol dependence and healthy volunteers using [11C]carfentanil PET and dexamphetamine challenge
    Turton, S.
    Mick, I.
    Myers, J.
    Colasanti, A.
    Bowden-Jones, H.
    Clark, L.
    Rabiner, E. A.
    Gunn, R. N.
    Nutt, D. J.
    Lingford-Hughes, A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2017, 37 : 97 - 97
12